Article Menu

Export Article

More by Authors Links

Article Data

  • Views 1257
  • Dowloads 113

Case Reports

Open Access

Mitotically active haemorrhagic cellular (apoplectic) leiomyoma

  • Y. L. Hock1,*,
  • P. Goswami2
  • T. P. Rollason3

1Department of Histopathology, Manor Hospital, Walsall, UK

2Department of Gynaecology, Manor Hrnpital, Walsall, UK

3Department of Histopathology, Birmingham Women's Hospital, Birmingham, UK

DOI: 10.12892/ejgo20000128 Vol.21,Issue 1,January 2000 pp.28-29

Published: 10 January 2000

*Corresponding Author(s): Y. L. Hock E-mail:

PDF (243.43 kB) View Full-text

Abstract

Apoplectic leiomyoma is a distinctive smooth muscle tumour usually occurring in women either taking oral contraceptives or who are pregnant or recently postpartum. Most of these tumours show 0-2 mitoses per 10 high power fields, but a mitotic index of up to 8 per 10 high power fields is allowed in such tumours. We describe an apoplectic leiomyoma with a number of atypical features including a high mitotic index (up to 20 per 10 high power fields) in a 47-year-old woman. Follow-up clinically and by computerised tomography (CT) for 3 years demonstrates no recurrence.

Keywords

Apoplectic leiomyoma; Atypical features; Mitotic index

Cite and Share

Y. L. Hock,P. Goswami,T. P. Rollason. Mitotically active haemorrhagic cellular (apoplectic) leiomyoma. European Journal of Gynaecological Oncology. 2000. 21(1);28-29.

URL:

https://www.ejgo.net/articles/10.12892/ejgo20000128

References

[1] Norris H. G., Hilliard G.D., Irey N. S.: "Haemorrhagic eellular leiomyoma (apopletic leiomyoma) of uterus associated with pregnancy and contraception". Int. J. Gynaecol Pathol., 1988, 7, 212.

[2] Myles J. L., Hart W. R.: "Apopletic leiomyomas of the uterus. A clinicopathologic study of five distinctive haemorrhagic leiomyomas associated with oral contraceptive usage". Am. J. Surg. Pathol., 1985, 9, 798.

[3] Bell S. W., Kempson R. L., Hendrickson M. R.: "Problematic uterine smooth muscle neoplasms. A clinicopathologic study of213 cases".Am. J. Surg. Pathol., 1994, 18, 535.

Submission Turnaround Time

Top